Nahdi Medical Co. Announces its Interim Financial Results for the Period Ending on 2026-06-30 ( Six Months )

Nahdi Medical Company reported a net profit of SAR 450.9 million for H1 2026, representing an 8.6% decline from SAR 493.6 million in the prior-year period, despite a 5.9% increase in total revenue to SAR 5.47 billion.
Top-line growth was supported by a 34.6% revenue surge in the Healthcare segment and strong digital momentum, with omnichannel sales now contributing 30.2% of total revenue compared to 24.8% last year.
Profitability was pressured by a gross margin contraction to 36.5% (down from 37.0%) and increased operating expenses, driven by planned strategic investments in AI-enabled capabilities, digital transformation, and the expansion of the "Nahdicare" polyclinic network.
The Board of Directors approved a cash dividend of SAR 2.60 per share for the first half of 2026, while the company reaffirmed its full-year guidance targeting 6%–8% sales growth and 1%–2% net profit growth.

Element List	Current Quarter	Similar quarter for previous year	%Change	Previous Quarter	% Change
Sales/Revenue	2,674.3	2,527.6	5.803	2,794.4	-4.297
Gross Profit (Loss)	1,007.6	966	4.306	987.7	2.014
Operational Profit (Loss)	245.9	260.6	-5.64	259.7	-5.313
Net Profit (Loss) Attributable to Shareholders of the Issuer	215.2	238.4	-9.731	235.7	-8.697
Total Comprehensive Income Attributable to Shareholders of the Issuer	234	239.4	-2.255	262.1	-10.721
All figures are in (Millions) Saudi Arabia, Riyals

Element List	Current Period	Similar period for previous year	%Change
Sales/Revenue	5,468.7	5,162.5	5.931
Gross Profit (Loss)	1,995.4	1,909.8	4.482
Operational Profit (Loss)	505.6	530.6	-4.711
Net Profit (Loss) Attributable to Shareholders of the Issuer	450.9	493.6	-8.65
Total Comprehensive Income Attributable to Shareholders of the Issuer	496.2	492.4	0.771
Total Shareholders Equity (after Deducting Minority Equity)	2,511.7	2,688.5	-6.576
Profit (Loss) per Share	3.47	3.8
All figures are in (Millions) Saudi Arabia, Riyals

Element List	Amount	Percentage of the capital (%)
Profit (Losses) Resulting From The Change In Investment Propertie’s Fair Value	-	-
All figures are in (Millions) Saudi Arabia, Riyals

Element List	Explanation
The reason of the increase (decrease) in the sales/ revenues during the current quarter compared to the same quarter of the last year is	Revenue: Nahdi Medical Company’s revenue increased by 5.8% in the second quarter of 2026, reaching SAR 2,674.3 million compared to SAR 2,527.6 million in the same quarter last year. The Retail business delivered a 4.1 % increase. Additionally, the Healthcare and the regional expansion businesses continued their upward momentum, recording growth of 36.9% and 24.6%, respectively (please refer to the attached press release for detailed analysis).
The reason of the increase (decrease) in the net profit during the current quarter compared to the same quarter of the last year is	Net Profit: The Company reported a net profit of SAR 215.2 million, compared to SAR 238.4 million in the same quarter last year, lower by 9.7% or SAR 23.2 million. This result is attributed to the following reasons: -Gross Profit: Gross profit increased by 4.3% or SAR 41.7 million year-over-year to reach SAR 1,007.6 million, compared to SAR 966.0 million in the same quarter last year, driven by higher revenue. Meanwhile, gross margin landed at 37.7% compared to 38.2% in the same quarter last year. This performance reflects the change in business mix with the accelerated growth in healthcare, online and ongoing investments to support revenue growth. -Operating Profit: Operating profit reached SAR 245.9 million compared to SAR 260.6 million in the same quarter last year, lower by 5.7% or SAR 14.8 million, mainly due to higher operating expenses incurred to support strategic growth initiatives, healthcare expansion and digital capabilities. Furthermore, there was a net increase in expenses of SAR 8.4 million in items below operating profit. As a result, net profit reached SAR 215.2 million.
The reason of the increase (decrease) in the sales/ revenues during the current quarter compared to the previous one is	Revenue: The Company's revenue decreased by 4.3% or SAR 120.2 million to reach SAR 2,674.3 million in the second quarter of 2026 compared to SAR 2,794.4 million in the previous quarter, mainly due to seasonality as the first quarter benefited from the sales uplift associated with Ramadan season.
The reason of the increase (decrease) in the net profit (loss) during the current quarter compared to the previous one is	Net Profit: The Company delivered a net profit of SAR 215.2 million in the second quarter of 2026, compared to SAR 235.7 million in the previous quarter.
The reason of the increase (decrease) in the sales/ revenues during the current period compared to the same period of the last year is	Revenue: For the first half of 2026, Nahdi Medical Company’s revenue increased by 5.9% to reach SAR 5,468.7 million compared to SAR 5,162.5 million in the same period last year, an increase of SAR 306.2 million. The Retail business delivered a 4.4% increase, driven by growth in both Pharma and Front Shop segments. Additionally, the Healthcare and the regional expansion businesses continued their upward momentum, delivering a year-over-year growth of 34.6% and 28%, respectively.
The reason of the increase (decrease) in the net profit during the current period compared to the same period of the last year is	Net Profit: The Company reported a net profit of SAR 450.9 million in the first half of 2026 compared to SAR 493.6 million in the same period last year, reflecting a year-over-year decline of 8.6% or SAR 42.7 million, driven by the following reasons: -Gross Profit: Gross profit increased by 4.5% or SAR 85.6 million to reach SAR 1,995.4 million compared to SAR 1,909.8 million in the same period last year, driven by revenue growth. Meanwhile, gross margin landed at 36.5% compared to 37.0% in the same period last year. This performance reflects the change in business mix with the accelerated growth in healthcare, online and ongoing investments to support revenue growth. -Operating Profit: Operating profit reached SAR 505.6 million compared to SAR 530.6 million in the same period last year, lower by 4.7% or SAR 25.0 million, mainly due to higher operating expenses incurred to support strategic growth initiatives, healthcare expansion and digital capabilities. Items below operating profit reflected a net increase in expenses of SAR 17.6 million. As a result, net profit reached SAR 450.9 million.
Statement of the type of external auditor's report	Unmodified conclusion
Comment mentioned in the external auditor’s report, mentioned in any of the following paragraphs (other matter, conservation, notice, disclaimer of opinion, or adverse opinion)	NA
Reclassification of Comparison Items	- Certain comparative information has been reclassified to align with the current presentation for the period ending 30 June 2026.
Additional Information	- Other Comprehensive Income increased due to decrease in actuarial expense resulted from re-assessment of the actuarial estimate for the end-of-service indemnity. - In accordance with the Company’s governance, it strictly adheres to Shariah principles in all areas of its business, including banking and investment activities. As a result, all costs incurred, and revenues generated from these activities are Shariah-compliant.
Attached Documents	Attached Documents